• Save
Eshlsg medical-education-survey-results-june2013
Upcoming SlideShare
Loading in...5
×
 

Eshlsg medical-education-survey-results-june2013

on

  • 1,859 views

In July 2013 at the BMJ/ABPI Conference on medical education the ESHLSG made public the results of its survey on attitudes to industry support of medical education.

In July 2013 at the BMJ/ABPI Conference on medical education the ESHLSG made public the results of its survey on attitudes to industry support of medical education.

Statistics

Views

Total Views
1,859
Views on SlideShare
425
Embed Views
1,434

Actions

Likes
0
Downloads
0
Comments
0

4 Embeds 1,434

http://market-it.fr 1416
http://kbcrawl-prod.grs.net 12
http://webcache.googleusercontent.com 4
https://www.google.fr 2

Accessibility

Upload Details

Uploaded via as Adobe PDF

Usage Rights

CC Attribution-ShareAlike LicenseCC Attribution-ShareAlike License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Eshlsg medical-education-survey-results-june2013 Eshlsg medical-education-survey-results-june2013 Presentation Transcript

  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Prepared for: Ethical Standards in Health & Life Sciences Group By: Jane Fligelstone – The Consortium
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Objectives of the Survey • To understand attitudes and beliefs towards Pharmaceutical Sponsored Medical Education events (PSME) • To identify what aspects of PSME, if any, cause reputational harm to the industry / medical community and should be changed or stopped • To understand what elements of industry support across the spectrum of education, training and meetings are valued / not valued by the medical community NB: This project was funded by the ABPI.
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Two Stage Methodology Qualitative 70 In-Depth Interviews Quantitative Online Survey Timings 1485 Responses Qualitative Research January – April 2012 Survey live October 29th 2012 – February 22nd 2013
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Considerations • This is not intended to be academic research, it is a qualitative and quantitative survey of attitudes and opinions • The internet survey was open to all health care professionals, however participation was not obligatory • As a result, not all specialties, disciplines or sample groups are represented • The research was not intended to provide definitive solutions, it was designed to provide a platform to develop wider understanding of the issues
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Overall Sample Total Response 1485 Health Care Professionals 1202 • Doctor – Primary Care 29 • Doctor – Secondary Care Excluding Psychiatrists (SCEP) 678 • Psychiatrist (P) 453 • Nurse 7 • Pharmacist / Medicines Management 31 Health Care Manager 21 Pharmaceutical Medicine – Commercial Organisation 126 Pharmaceutical Medicine – Academic Institution 44 None of above 61
  • Results EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION The Future of PSME Should the industry continue providing Medical Education for HCPs? SCEP 77% P 47% 23% Yes, should continue 53% No, should not continue
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Value of different types of meeting Extremely valuable Quite valuable Not valuable SCEP 20% (N=649) 61% 44% (N=602) P 19% 49% 13% Local 7% National European 25% (N=399) 64% 30% 7% (N=348) 62% 32% 6% International 0% 50% 100% 57% 30% 58% 39% 0% 18% 37% 50% (N=360) 16% 45% 52% (N=436) (N=183) 11% 100% (N=141)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Key Considerations Undue CHALLENGES Influence FACING PSME Aligning Agendas Impact of PSME Contribution from PSME
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Undue Influence Neutral/Don’t know Agree/strongly By allowing so much of medical education to be provided by pharmaceutical companies, the NHS is leaving an opening for bias and undue influence SCEP Attending an Industry sponsored medical education event means there is a possibility that HCPs might be influenced to use a company's products SCEP 54% P 24% 66% 16% 11% 84% 0% 22% 18% 80% P Disagree/strongly 9% 50% 9% 7% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Undue Influence Neutral/Don’t know Agree/strongly The NHS should be wary of the influence the pharmaceutical industry could exert through their sponsorship of medical education Less experienced/discerning colleagues may be unduly influenced by medical education sponsored by the Industry SCEP 72% P 13% 81% SCEP 17% 78% 0% 15% 11% 74% P Disagree/strongly 15% 50% 8% 9% 7% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Aligning Agendas Neutral/Don’t know Agree/strongly Much of the medical education provided by the pharmaceutical industry is directed by their agenda rather than the needs of HCPs Pharmaceutical companies must get some financial benefit from sponsoring medical education, otherwise they would not do it SCEP 51% P 30% 68% SCEP 11% 16% 82% 0% 19% 21% 74% P Disagree/strongly 12% 50% 10% 6% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Aligning Agendas Neutral/Don’t know Agree/strongly It is important to ensure that medical education events sponsored by the pharmaceutical industry are nonpromotional The relationship between HCPs and the pharmaceutical industry can be mutually beneficial as long as everyone knows what the agenda is Disagree/strongly SCEP 80% 15% 5% P 81% 12% 7% SCEP 82% 9% 9% P 65% 0% 14% 50% 21% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Contribution from PSME Neutral/Don’t know Agree/strongly Pharmaceutical companies have a responsibility via medical education to invest in the health care system from which they derive their profits The pharmaceutical industry is a legitimate source of information and education with regard to new products SCEP 68% P 21% 52% SCEP 23% 73% P 11% 25% 16% 57% 0% Disagree/strongly 19% 50% 11% 24% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Contribution from PSME Neutral/Don’t know Agree/strongly There is a great deal of scientific knowledge and expertise within pharmaceutical companies, so they have a genuine contribution to make via sponsored medical education Medical education is an opportunity for pharmaceutical companies to put something back into the NHS SCEP 68% P 19% 51% SCEP 24% 66% P 43% 0% Disagree/strongly 13% 25% 18% 24% 50% 16% 33% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Impact of PSME Neutral/Don’t know Agree/strongly SCEP I believe that industry sponsored medical education improves patient care Industry sponsored medical education meetings allow me to reflect on my practice and how I might be able to improve it 54% P 37% SCEP 30% 30% 62% P 16% 33% 21% 45% 0% Disagree/strongly 23% 50% 17% 32% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Impact of PSME Neutral/Don’t know Agree/strongly Industry sponsored medical education helps me keep up to date in my speciality and as a result my patients benefit from better care SCEP 69% P 17% 51% 0% Disagree/strongly 22% 50% 14% 27% 100% Statistically higher/lower than Psychiatrists at 95% level of confidence Base: SCEP= Secondary Care respondents exc. Psychiatrists n= 678; P=Psychiatrists n=453)
  • EVALUATING THE ROLE OF PHARMA SPONSORED MEDICAL EDUCATION Key Findings • PSME is generally valued and the contribution to the NHS and HCPs is acknowledged • Issues that need to be addressed include transparency of agendas, greater collaboration on educational agendas and clear differentiation between non-promotional and promotional events • The research has identified specific areas for the ESHLSG to be explored
  • Thank You For any questions, please contact: info@eshlsg.org